The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
Open accessAbstract
SUMMARY: Polymyxins are well-established antibiotics that have recently regained significant interest as a consequence of the increasing incidence of infections due to multidrug-resistant Gram-negative bacteria. Colistin and polymyxin B are being seriously reconsidered as last-resort antibiotics in many areas where multidrug resistance is observed in clinical medicine. In parallel, the heavy use of polymyxins in veterinary medicine is currently being reconsidered due to increased reports of polymyxin-resistant bacteria. Susceptibility testing is challenging with polymyxins, and currently available techniques are presented here. Genotypic and phenotypic methods that provide relevant information for diagnostic laboratories are presented. This review also presents recent works in relation to recently identified mechanisms of polymyxin resistance, including chromosomally encoded resistance traits as well as the recently identified plasmid-encoded polymyxin resistance determinant MCR-1. Epidemiological features summarizing the current knowledge in that field are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
Jorgensen, J. H., & Ferraro, M. J. (2009) · Clinical Infectious Diseases · doi:10.1086/647952 · Cited by 1,894
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046
The Pleiotropic Two-Component Regulatory System PhoP-PhoQ
Groisman, E. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.6.1835-1842.2001 · Cited by 887
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Xavier, B. B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., & Malhotra-Kumar, S. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.27.30280 · Cited by 779
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 565
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides
Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Albertí, S., & Bengoechea, J. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7107-7114.2004 · Cited by 518
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Colistin, mechanisms and prevalence of resistance
Bialvaei, A. Z., & Kafil, H. S. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1018989 · Cited by 460
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence
Padilla, E., Llobet, E., Doménech-Sánchez, A., Martínez-Martínez, L., Bengoechea, J. A., & Albertí, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00715-09 · Cited by 431
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Hasman, H., Hammerum, A. M., Hansen, F., Hendriksen, R. S., Olesen, B., Agersø, Y., Zankari, E., Leekitcharoenphon, P., Stegger, M., Kaas, R. S., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es.2015.20.49.30085 · Cited by 419
Bellomo, R., Kellum, J. A., & Ronco, C. (2007) · Intensive Care Medicine · doi:10.1007/s00134-006-0478-x · Cited by 389
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Cannatelli, A., Giani, T., D'Andrea, M. M., Di Pilato, V., Arena, F., Conte, V., Tryfinopoulou, K., Vatopoulos, A., & Rossolini, G. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03110-14 · Cited by 374
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
McGann, P., Snesrud, E., Maybank, R., Corey, B., Ong, A. C., Clifford, R., Hinkle, M., Whitman, T., Lesho, E., & Schaecher, K. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-16 · Cited by 350
Capone, A., Giannella, M., Fortini, D., Giordano, A., Meledandri, M., Ballardini, M., Venditti, M., Bordi, E., Capozzi, D., Balice, M. P., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12070 · Cited by 346
Gales, A. C., Jones, R. N., & Sader, H. S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr239 · Cited by 337
Gunn, J. S. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.03.007 · Cited by 332
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Nation, R. L., Velkov, T., & Li, J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu213 · Cited by 310
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
Poirel, L., Jayol, A., Bontron, S., Villegas, M.-V., Ozdamar, M., Turkoglu, S., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku323 · Cited by 302
Self-citationResistance to polymyxins: Mechanisms, frequency and treatment options
Falagas, M. E., Rafailidis, P. I., & Matthaiou, D. K. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.002 · Cited by 298
Olaitan, A. O., Diene, S. M., Kempf, M., Berrazeg, M., Bakour, S., Gupta, S. K., Thongmalayvong, B., Akkhavong, K., Somphavong, S., Paboriboune, P., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.020 · Cited by 292
A review on colistin nephrotoxicity
Ordooei Javan, A., Shokouhi, S., & Sahraei, Z. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1865-4 · Cited by 287
Falgenhauer, L., Waezsada, S.-E., Yao, Y., Imirzalioglu, C., Käsbohrer, A., Roesler, U., Michael, G. B., Schwarz, S., Werner, G., Kreienbrock, L., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00009-8 · Cited by 282
Early emergence of mcr-1 in Escherichia coli from food-producing animals
Shen, Z., Wang, Y., Shen, Y., Shen, J., & Wu, C. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00061-x · Cited by 277
Arroyo, L. A., Herrera, C. M., Fernandez, L., Hankins, J. V., Trent, M. S., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00256-11 · Cited by 275
Antoniadou, A., Kontopidou, F., Poulakou, G., Koratzanis, E., Galani, I., Papadomichelakis, E., Kopterides, P., Souli, M., Armaganidis, A., & Giamarellou, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl562 · Cited by 273
China bans colistin as a feed additive for animals
Walsh, T. R., & Wu, Y. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30329-2 · Cited by 269
Doumith, M., Godbole, G., Ashton, P., Larkin, L., Dallman, T., Day, M., Day, M., Muller-Pebody, B., Ellington, M. J., de Pinna, E., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw093 · Cited by 263
Colistin: new lessons on an old antibiotic
Yahav, D., Farbman, L., Leibovici, L., & Paul, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03734.x · Cited by 259
Dissemination of the mcr-1 colistin resistance gene
Zhi, C., Lv, L., Yu, L.-F., Doi, Y., & Liu, J.-H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00063-3 · Cited by 258
Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids
Haenni, M., Poirel, L., Kieffer, N., Châtre, P., Saras, E., Métayer, V., Dumoulin, R., Nordmann, P., & Madec, J.-Y. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00007-4 · Cited by 256
Self-citationDalfino, L., Puntillo, F., Mosca, A., Monno, R., Spada, M. L., Coppolecchia, S., Miragliotta, G., Bruno, F., & Brienza, N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis286 · Cited by 247
Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1
Yao, X., Doi, Y., Zeng, L., Lv, L., & Liu, J.-H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00057-8 · Cited by 245
Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01406-06 · Cited by 242
Hindler, J. A., & Humphries, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-12 · Cited by 241
Dissemination of the mcr-1 colistin resistance gene
Arcilla, M. S., van Hattem, J. M., Matamoros, S., Melles, D. C., Penders, J., de Jong, M. D., & Schultsz, C. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00541-1 · Cited by 240
Feedback Inhibition in the PhoQ/PhoP Signaling System by a Membrane Peptide
Lippa, A. M., & Goulian, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000788 · Cited by 238
Catry, B., Cavaleri, M., Baptiste, K., Grave, K., Grein, K., Holm, A., Jukes, H., Liebana, E., Navas, A. L., Mackay, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.06.005 · Cited by 238
Mohamed, A. F., Karaiskos, I., Plachouras, D., Karvanen, M., Pontikis, K., Jansson, B., Papadomichelakis, E., Antoniadou, A., Giamarellou, H., Armaganidis, A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06426-11 · Cited by 234
Fernandes, M. R., Moura, Q., Sartori, L., Silva, K. C., Cunha, M. P., Esposito, F., Lopes, R., Otutumi, L. K., Gonçalves, D. D., Dropa, M., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.17.30214 · Cited by 232
Moskowitz, S. M., Brannon, M. K., Dasgupta, N., Pier, M., Sgambati, N., Miller, A. K., Selgrade, S. E., Miller, S. I., Denton, M., Conway, S. P., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05829-11 · Cited by 230
Dissemination of the mcr-1 colistin resistance gene
Olaitan, A. O., Chabou, S., Okdah, L., Morand, S., & Rolain, J.-M. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00540-x · Cited by 228
Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae
Du, H., Chen, L., Tang, Y.-W., & Kreiswirth, B. N. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00056-6 · Cited by 226
Monaco, M., Giani, T., Raffone, M., Arena, F., Garcia-Fernandez, A., Pollini, S., Network EuSCAPE-Italy, C., Grundmann, H., Pantosti, A., & Rossolini, G. M. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.42.20939 · Cited by 226
Sorlí, L., Luque, S., Grau, S., Berenguer, N., Segura, C., Montero, M. M., Álvarez-Lerma, F., Knobel, H., Benito, N., & Horcajada, J. P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-380 · Cited by 225
Miller, A. K., Brannon, M. K., Stevens, L., Johansen, H. K., Selgrade, S. E., Miller, S. I., Høiby, N., & Moskowitz, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05391-11 · Cited by 224
Srinivasan, V. B., & Rajamohan, G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02284-12 · Cited by 216
Wright, M. S., Suzuki, Y., Jones, M. B., Marshall, S. H., Rudin, S. D., van Duin, D., Kaye, K., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04037-14 · Cited by 216
Deris, Z. Z., Akter, J., Sivanesan, S., Roberts, K. D., Thompson, P. E., Nation, R. L., Li, J., & Velkov, T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.111 · Cited by 216
Hussein, K., Sprecher, H., Mashiach, T., Oren, I., Kassis, I., & Finkelstein, R. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/598244 · Cited by 215
Marchaim, D., Chopra, T., Pogue, J. M., Perez, F., Hujer, A. M., Rudin, S., Endimiani, A., Navon-Venezia, S., Hothi, J., Slim, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-10 · Cited by 208
Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli
Poirel, L., Kieffer, N., Liassine, N., Thanh, D., & Nordmann, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00006-2 · Cited by 208
Self-citationCheah, S.-E., Wang, J., Nguyen, V. T. T., Turnidge, J. D., Li, J., & Nation, R. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv267 · Cited by 206
Akajagbor, D. S., Wilson, S. L., Shere-Wolfe, K. D., Dakum, P., Charurat, M. E., & Gilliam, B. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit453 · Cited by 205
Rapid Detection of Polymyxin Resistance in Enterobacteriaceae
Nordmann, P., Jayol, A., & Poirel, L. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2206.151840 · Cited by 204
Self-citationJayol, A., Nordmann, P., Brink, A., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05055-14 · Cited by 203
Self-citationColistin resistance in Klebsiella pneumoniae
Ah, Y.-M., Kim, A.-J., & Lee, J.-Y. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.016 · Cited by 200
Moffatt, J. H., Harper, M., Adler, B., Nation, R. L., Li, J., & Boyce, J. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01732-10 · Cited by 196
Markou, N., Markantonis, S. L., Dimitrakis, E., Panidis, D., Boutzouka, E., Karatzas, S., Rafailidis, P., Apostolakos, H., & Baltopoulos, G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.01.015 · Cited by 191
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
Halaby, T., al Naiemi, N., Kluytmans, J., van der Palen, J., & Vandenbroucke-Grauls, C. M. J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-12 · Cited by 182
Phe, K., Lee, Y., McDaneld, P. M., Prasad, N., Yin, T., Figueroa, D. A., Musick, W. L., Cottreau, J. M., Hu, M., & Tam, V. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02476-13 · Cited by 180
A Model for Transposition of the Colistin Resistance Gene mcr-1 by IS Apl1
Snesrud, E., He, S., Chandler, M., Dekker, J. P., Hickman, A. B., McGann, P., & Dyda, F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01457-16 · Cited by 180
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Lesho, E., Yoon, E.-J., McGann, P., Snesrud, E., Kwak, Y., Milillo, M., Onmus-Leone, F., Preston, L., St. Clair, K., Nikolich, M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit293 · Cited by 171
Yan, A., Guan, Z., & Raetz, C. R. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706172200 · Cited by 169
Bogdanovich, T., Adams-Haduch, J. M., Tian, G.-B., Nguyen, M. H., Kwak, E. J., Muto, C. A., & Doi, Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir401 · Cited by 168
Elucidation of the RamA Regulon in Klebsiella pneumoniae Reveals a Role in LPS Regulation
De Majumdar, S., Yu, J., Fookes, M., McAteer, S. P., Llobet, E., Finn, S., Spence, S., Monaghan, A., Kissenpfennig, A., Ingram, R. J., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004627 · Cited by 165
Matthaiou, D. K., Michalopoulos, A., Rafailidis, P. I., Karageorgopoulos, D. E., Papaioannou, V., Ntani, G., Samonis, G., & Falagas, M. E. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181652fae · Cited by 163
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., & Li, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.07.010 · Cited by 162
Barrow, K., & Kwon, D. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00893-09 · Cited by 162
Diene, S. M., Merhej, V., Henry, M., Filali, A. E., Roux, V., Robert, C., Azza, S., Gavory, F., Barbe, V., Scola, B. L., et al. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss236 · Cited by 160
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
Zowawi, H. M., Forde, B. M., Alfaresi, M. S., Alzarouni, A., Farahat, Y., Chong, T. M., Yin, W., Chan, K., Li, J., Schembri, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep15082 · Cited by 158
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Meletis, G., Tzampaz, E., Sianou, E., Tzavaras, I., & Sofianou, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr007 · Cited by 154
Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L., & Li, J. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.11.002 · Cited by 152
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 152
Dissemination of the mcr-1 colistin resistance gene
Webb, H. E., Granier, S. A., Marault, M., Millemann, Y., den Bakker, H. C., Nightingale, K. K., Bugarel, M., Ison, S. A., Scott, H. M., & Loneragan, G. H. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00538-1 · Cited by 148
Impact of food animal trade on the spread of mcr-1-mediated colistin resistance, Tunisia, July 2015
Grami, R., Mansour, W., Mehri, W., Bouallègue, O., Boujâafar, N., Madec, J.-Y., & Haenni, M. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.8.30144 · Cited by 145
Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam
Malhotra‐Kumar, S., Xavier, B. B., Das, A. J., Lammens, C., Hoang, H. T. T., Ngoc, P. T., & Goossens, H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00014-1 · Cited by 143
Cheng, Y.-H., Lin, T., Lin, Y.-T., & Wang, J.-T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00009-16 · Cited by 142
Dissemination of the mcr-1 colistin resistance gene
Hu, Y., Liu, F., Lin, I. Y. C., Gao, G. F., & Zhu, B. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00533-2 · Cited by 141
Bergen, P. J., Li, J., Nation, R. L., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm511 · Cited by 140
Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B
Gallardo‐Godoy, A., Muldoon, C. A., Becker, B., Elliott, A. G., Lash, L. H., Huang, J. X., Butler, M. S., Pelingon, R., Kavanagh, A. M., Ramu, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01593 · Cited by 138
Mammina, C., Bonura, C., Bernardo, F. D., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.33.20248-en · Cited by 137
Stoesser, N. E., Mathers, A. J., Moore, C. E., Day, N., & Crook, D. W. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00010-4 · Cited by 136
SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
Barnett, M., Bushby, S. R. M., & Wilkinson, S. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01610.x · Cited by 134
Prevalence of mcr-1 in commensal Escherichia coli from French livestock, 2007 to 2014
Perrin‐Guyomard, A., Bruneau, M., Houée, P., Deleurme, K., Grandois, P. L., Poirier, C., Soumet, C., & Sandérs, P. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.6.30135 · Cited by 134
Gutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E., Kaul, R., Johansen, H. K., Høiby, N., & Moskowitz, S. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02353-12 · Cited by 131
Chiu, S.-K., Wu, T., Chuang, Y.-C., Lin, J., Fung, C., Lu, P., Wang, J., Wang, L.-S., Siu, L.-K. K., & Yeh, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069428 · Cited by 130
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Ni, W., Li, Y., Guan, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00248-16 · Cited by 129
Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin
Tan, T. Y., & Ng, S. Y. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01708.x · Cited by 126
Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium
Sun, S., Negrea, A., Rhen, M., & Andersson, D. I. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01016-08 · Cited by 125
Structure of the catalytic domain of the colistin resistance enzyme MCR-1
Stojanoski, V., Sankaran, B., Prasad, B. V. V., Poirel, L., Nordmann, P., & Palzkill, T. G. (2016) · BMC Biology · doi:10.1186/s12915-016-0303-0 · Cited by 121
Self-citationGiani, T., Arena, F., Vaggelli, G., Conte, V., Chiarelli, A., Angelis, L. H. D., Fornaini, R., Grazzini, M., Niccolini, F., Pecile, P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01017-15 · Cited by 120
Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary
Tóth, Á., Damjanova, I., Puskás, E., Jánvári, L., Farkas, M., Dobák, A., Böröcz, K., & Pászti, J. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0921-3 · Cited by 119
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide
DIXON, R. A., & Chopra, I. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.5.781 · Cited by 112
A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates
Nordmann, P., Jayol, A., & Poirel, L. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00446-16 · Cited by 111
Self-citationKontopidou, F. V., Plachouras, D., Papadomichelakis, E., Koukos, G., Galani, I., Poulakou, G., Dimopoulos, G., Antoniadou, A., Armaganidis, A., & Giamarellou, H. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03649.x · Cited by 110
Thanh, D. P., Tuyen, H. T., Nguyen, T. N. T., The, H. C., Wick, R. R., Thwaites, G. E., Baker, S. G., & Holt, K. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw173 · Cited by 110
Vicari, G., Bauer, S. R., Neuner, E. A., & Lam, S. W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis909 · Cited by 107
den Bergh, M. K.-V., Huizinga, P., Bonten, M. J. M., Bos, M. P., Bruyne, K. D., Friedrich, A. W., Rossen, J. W. A., Savelkoul, P. H. M., & Kluytmans, J. A. J. W. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.9.30149 · Cited by 107
Dissemination of the mcr-1 colistin resistance gene
Mulvey, M. R., Mataseje, L. F., Robertson, J. A., Nash, J. J., Boerlin, P., Toye, B., Irwin, R. J., & Melano, R. G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00067-0 · Cited by 107
Rolain, J., Diene, S. M., Kempf, M., Gimenez, G., Robert, C., & Raoult, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01314-12 · Cited by 104
Schurek, K. N., Sampaio, J. L. M., Kiffer, C. R. V., Sinto, S. I., Mendes, C. M. F., & Hancock, R. E. W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01267-08 · Cited by 100
Comparison of three standardized disc susceptibility testing methods for colistin
Tan, T. Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl330 · Cited by 100
Mezzatesta, M. L., Gona, F., Caio, C., Petrolito, V., Sciortino, D., Sciacca, A., Santangelo, C., & Stefani, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03572.x · Cited by 99
Susceptibility Testing of the Polymyxins: Where Are We Now?
Humphries, R. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1505 · Cited by 99
Investigation of a plasmid genome database for colistin-resistance gene mcr-1
Suzuki, S., Ohnishi, M., Kawanishi, M., Akiba, M., & Kuroda, M. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00008-6 · Cited by 99
Zeng, K.-J., Doi, Y., Patil, S., Huang, X., & Tian, G. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00345-16 · Cited by 99
Pournaras, S., Poulou, A., Dafopoulou, K., Chabane, Y. N., Kristo, I., Makris, D. A., Hardouin, J., Cosette, P., Tsakris, A., & Dé, E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01439-13 · Cited by 91
Landman, D., Salamera, J., & Quale, J. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02129-13 · Cited by 89
Dosing of colistin—back to basic PK/PD
Bergen, P. J., Li, J., & Nation, R. L. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.07.004 · Cited by 86
Colistin Resistance Gene mcr-1 in Avian-Pathogenic Escherichia coli in South Africa
Perreten, V., Strauss, C., Collaud, A., & Gerber, D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00548-16 · Cited by 83
Maâlej, S., Méziou, M., Rhimi, F., & Hammami, A. (2011) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2011.03145.x · Cited by 80
Olaitan, A. O., Dia, N. M., Gautret, P., Benkouiten, S., Belhouchat, K., Drali, T., Parola, P., Brouqui, P., Memish, Z. A., Raoult, D., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.01.010 · Cited by 78
Dissemination of the mcr-1 colistin resistance gene
Tse, H., & Yuen, K. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00532-0 · Cited by 77
Suh, J.-Y., Son, J. S., Chung, D. R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00762-09 · Cited by 70
López‐Camacho, E., Gómez-Gil, R., Tobes, R., Manrique, M., Lorenzo, M., Galván, B., Salvarelli, E., Moatassim, Y., Salanueva, Í. J., Pareja, E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt419 · Cited by 70
Lee, S. Y., Shin, J. H., Lee, K., Joo, M. Y., Park, K. H., Shin, M., Suh, S., Ryang, D. W., & Kim, S. H. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00427-13 · Cited by 69
Colistin: How should It Be Dosed for the Critically Ill?
Landersdorfer, C. B., & Nation, R. L. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398390 · Cited by 69
Signal‐specific temporal response by the S almonella PhoP / PhoQ regulatory system
Park, S. J., & Groisman, E. A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12449 · Cited by 69
Liu, B., Song, F., Zou, M., Hao, Z., & Shan, H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-16 · Cited by 68
Girardello, R., Bispo, P. J. M., Yamanaka, T. M., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06686-11 · Cited by 67
Reversal of the Antibacterial Activity of Polymyxin by Divalent Cations
Newton, B. A. (1953) · Nature · doi:10.1038/172160a0 · Cited by 67
Moskowitz, S. M., Garber, E., Chen, Y., Clock, S. A., Tabibi, S., Miller, A. K., Doctor, M., & Saiman, L. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq131 · Cited by 65
Boyen, F., Vangroenweghe, F. A. C. J., Butaye, P., Graef, E. D., Castryck, F., Heylen, P., Vanrobaeys, M., & Haesebrouck, F. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.01.010 · Cited by 61
Sutherland, C. A., & Nicolau, D. P. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.501 · Cited by 60
Serratia marcescens arn , a PhoP-Regulated Locus Necessary for Polymyxin B Resistance
Lin, Q. Y., Tsai, Y.-L., Liu, M.-C. J., Lin, W.-C., Hsueh, P., & Liaw, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-14 · Cited by 60
Durante‐Mangoni, E., Franco, M. D., Andini, R., Bernardo, M., Giannouli, M., & Zarrilli, R. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.03.013 · Cited by 58
Pilonieta, M. C., Erickson, K. D., Ernst, R. K., & Detweiler, C. S. (2009) · Journal of Bacteriology · doi:10.1128/jb.00688-09 · Cited by 56
Plasmid-Mediated Colistin-ResistantEscherichia coliin Bacteremia in Switzerland
Nordmann, P., Lienhard, R., Kieffer, N., Clerc, O., & Poirel, L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw124 · Cited by 56
Self-citationKluyvera ascorbata Strain from Hospital Sewage Carrying the mcr-1 Colistin Resistance Gene
Zhao, F., & Zong, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-16 · Cited by 53
Brink, A. J., Richards, G. A., Colombo, G., Bortolotti, F., Colombo, P., & Jehl, F. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.013 · Cited by 53
Kim, Y., Bae, I. K., Lee, H., Jeong, S. H., Yong, D., & Lee, K. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.03.027 · Cited by 52
The in-vitro activity of colistin in gram-negative bacteria.
Tan, T. Y., & Ng, S. Y. (2006) · PubMed · Cited by 51
Jiang, S.-S., Liu, M.-C. J., Teng, L., Wang, W.-B., Hsueh, P., & Liaw, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01219-09 · Cited by 48
Strenger, V., Gschliesser, T., Grisold, A. J., Zarfel, G., Feierl, G., Masoud, L., Hoenigl, M., Resch, B., Müller, W. D., & Urlesberger, B. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.010 · Cited by 47
Tijet, N., Sheth, P. M., Lastovetska, O., Chung, C., Patel, S. N., & Melano, R. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116421 · Cited by 46
Sader, H. S., Rhomberg, P. R., Farrell, D. J., & Jones, R. N. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.08.013 · Cited by 43
Chen, S., Hu, F., Zhang, X., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01233-11 · Cited by 43
Rapid Detection of Polymyxin-Resistant Enterobacteriaceae from Blood Cultures
Jayol, A., Dubois, V., Poirel, L., & Nordmann, P. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00918-16 · Cited by 41
Self-citationSınırtaş, M., Akalın, H., & Gedikoğlu, S. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.12.012 · Cited by 31
Perez, L. R. R. (2015) · Apmis · doi:10.1111/apm.12438 · Cited by 24
Sautrey, G., Duval, R. E., Chevalley, A., Fontanay, S., & Clarot, I. (2015) · Electrophoresis · doi:10.1002/elps.201500064 · Cited by 17
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021) · Pathogens · doi:10.3390/pathogens10020165 · Cited by 1,039
Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., & Bezirtzoglou, E. (2021) · Microorganisms · doi:10.3390/microorganisms9102041 · Cited by 993
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Metadata
- Authors
- Poirel, L., Jayol, A., & Nordmann, P.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2017-04
- Volume
- 30
- Issue
- 2
- Pages
- 557-596
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2593444269
- Cited by
- 1,447
- References
- 165
- FWCI
- 49.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.